A new therapeutic model for T-cell engineering promises to make it a more precise weapon that can tackle solid tumors while avoiding off-target reactions that threaten patients.
The division, which the company has set up to meet rising demand for postapproval research, will make use of BioClinica's technology capabilities.
Royal Philips has named Jean Botti as chief innovation and strategy officer in its effort to shift its business to focus exclusively on HealthTech. The conglomerate has been in the throes of this strategy shift for more than a year, but recently was dealt a blow when a deal recently fell through for one of its two lighting businesses that it's working to divest after U.S. regulators objected to the purchase by a Chinese investor.
Merck is buying into a Cancer Research U.K. program that targets an enzyme key to the development of cancer and blood disease, wagering as much as $515 million on the effort.
It's not a new argument, but it's back on the table again now in a big way. Activist investor Artisan Partners is working to convince other investors to back splitting conglomerate Johnson & Johnson into three separate businesses.
Sanofi's animal health division, Merial, has been exploring ways to integrate new technology into their product offerings. They stepped up that effort on January 28, announcing a partnership with the Georgia Institute of Technology that's centered on using connected devices to advance animal health.
CRO giant Parexel has inked a new pact with the Optum Life Sciences unit of the nation's largest insurer, UnitedHealth Group, to help lower costs in postapproval studies.
Abbott has partnered with Chicago, IL-based Matter, a healthcare technology incubator, in its latest bid to access innovation. The diversified conglomerate, which markets nutrition, diagnostics, established pharmaceutical and medical device products, is under pressure to improve revenue growth and profitability in the wake of its 2013 split from the biopharma R&D-oriented AbbVie.
The University of Southern California Center for Body Computing has teamed with 8 partners to launch a Virtual Care Clinic. The idea with VCC is to create an integrated approach to the use of mobile apps, "virtual" doctors, artificial intelligence, data collection and analysis, as well as diagnostics and wearable sensors to create truly on-demand healthcare.
Minneapolis-based Minnetronix was founded in 1996 to offer engineering and manufacturing services to medical device companies. Now, it's raised its first equity capital since its inception with a $20 million investment from Altaris Capital Partners that gives the healthcare private equity firm a minority stake.